SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-070561
Filing Date
2024-06-07
Accepted
2024-06-07 16:00:05
Documents
2
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3677
2 EX-24.1 cue-ex24_1.htm EX-24.1 8982
  Complete submission text file 0000950170-24-070561.txt   14159
Mailing Address C/O PARK CITY CAPITAL, LLC 100 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address
Fox Michael J (Reporting) CIK: 0001589232 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38327 | Film No.: 241029126

Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)